Yehuda Eliya - 05 Dec 2022 Form 4 Insider Report for Raphael Pharmaceutical Inc. (RAPH)

Role
Chief Financial Officer, Director
Signature
/s/ Yehuda Eliya
Issuer symbol
RAPH
Transactions as of
05 Dec 2022
Net transactions value
$0
Form type
4
Filing time
13 Mar 2023, 16:03:22 UTC
Previous filing
12 Mar 2025
Next filing
25 Mar 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RAPH Warrants to Purchase Common Stock Award $0 +202,000 $0.000000 202,000 05 Dec 2022 Common Stock 202,000 $1.12 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The warrants are exercisable immediately.